Psoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.
Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Explore how sponsors can stay ahead of evolving regulatory demands, tech shifts, and enrollment pressures in today’s complex clinical trial landscape.
Discover how natural history data, external controls, and RWE are reshaping rare neurological disease trials for smarter, regulatory-ready design.
Discover how TFS is helping sponsors prepare for ICH E6(R3) with proactive oversight, modern technologies, and quality-first trial design.
From digital biomarkers to AI-enabled feasibility, explore the top trends reshaping CNS clinical trials in 2025 and how innovative CROs are helping sponsors bring neuroscience clinical research to life.
Explore a decade of progress and the critical next steps in LGBTQIA+ clinical trial inclusion.
Learn how TFS honors Juneteenth by promoting diversity and inclusion in clinical trials to improve global health outcomes.
Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.
Explore how decentralized clinical trials (DCTs) are transforming clinical research in 2025 through technologies like telehealth, wearables, and digital platforms.
Discover how the FSP model enhances trial agility, oversight, and scalability, providing a strategic advantage in 2025 clinical development.
Explore the latest advancements in Huntington’s disease therapeutics—from gene silencing and small molecules to digital biomarkers.
Learn how emerging therapies and technologies from ARVO are transforming the landscape of ophthalmology research, and why strategic partners like TFS are key to advancing clinical success.
Explore ten standout biotech and specialty pharma companies driving innovation in the UK and Ireland.
Explore 10 emerging East Coast biotech companies driving innovation in 2025 across CNS, oncology, and dermatology clinical research.
